Endovascular treatment for superior vena cava obstruction in Behçet disease.
Behçet disease is a heterogeneous, multisystem inflammatory disorder; vascular involvement has been considered to result from systemic vasculitis, which most frequently affects veins and occurs in 5% to 10% of these patients. However, superior vena cava (SVC) involvement is rare; it accounts for only 6% of the cases. The aim of this article is to a report on a case of SVC recanalization through the use of fibrinolysis and self-expanding stents as treatment of life-threatening SVC syndrome in a young male patient with Behçet disease.
Castelli
Patrizio
P
Post-Graduate School in Vascular Surgery, Department of Surgery, University of Insubria, viale Borri 57, Varese 21100, Italy.
Caronno
Roberto
R
Piffaretti
Gabriele
G
Tozzi
Matteo
M
Lomazzi
Chiara
C
Laganà
Domenico
D
Carrafiello
Gianpaolo
G
Cuffari
Salvatore
S
D000328:Adult; D001528:Behcet Syndrome / Q000150:complications* / Q000628:therapy; D002404:Catheterization; D006801:Humans; D008297:Male; D010960:Plasminogen Activators / Q000627:therapeutic use; D011859:Radiography; D015607:Stents; D013479:Superior Vena Cava Syndrome / Q000000981:diagnostic imaging / Q000209:etiology / Q000628:therapy*; D015912:Thrombolytic Therapy; D014568:Urokinase-Type Plasminogen Activator / Q000627:therapeutic use
D010960:Plasminogen Activators; D014568:Urokinase-Type Plasminogen Activator